4//SEC Filing
Templeman Thomas 4
Accession 0001847903-23-000030
CIK 0001847903other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:47 PM ET
Size
5.5 KB
Accession
0001847903-23-000030
Insider Transaction Report
Form 4
Templeman Thomas
Chief Technology Officer
Transactions
- Tax Payment
Ordinary Shares
2022-09-30$4.25/sh−5,382$22,874→ 134,868 total
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
- [F3]Shares held by the Reporting Person after the reported transaction herein and does not include shares acquired or disposed of in subsequent reported transactions after September 30, 2022.
- [F4]As of year end December 31, 2022, the Reporting Person held 131,947 shares directly.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001654274
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:47 PM ET
- Size
- 5.5 KB